WO2025177220 - ALTERNATIVE SELF-AMPLIFYING RNA
National phase entry is expected:
Publication Number
WO/2025/177220
Publication Date
28.08.2025
International Application No.
PCT/IB2025/051865
International Filing Date
21.02.2025
Title **
[English]
ALTERNATIVE SELF-AMPLIFYING RNA
[French]
ARN AUTO-AMPLIFICATEUR ALTERNATIF
Applicants **
SEQIRUS INC.
Inventors
CHANG, Cheng
PHILIP, Asha
Priority Data
63/556,098
21.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2786 | |
| EPO | Filing, Examination, Granting | 20605 | |
| Japan | Filing, Examination, Granting | 2647 | |
| South Korea | Filing, Examination, Granting | 3192 | |
| USA | Filing, Examination, Granting | 16710 |
Total:
45,940
Contact Us
Abstract[English]
The present disclosure provides a self-amplifying RNA (sa-mRNA) comprising an open reading frame encoding a replicase or a non-structural protein 4 (nsP4) and an open reading frame encoding peptide or polypeptide, wherein the open reading frame encoding the peptide or polypeptide is co-expressed with the replicase or nsP4.[French]
La présente divulgation concerne un ARN auto-amplificateur (ARNm-aa) comprenant un cadre de lecture ouvert codant pour une réplicase ou une protéine non structurale 4 (nsP4) et un cadre de lecture ouvert codant pour un peptide ou un polypeptide, le cadre de lecture ouvert codant pour le peptide ou le polypeptide étant co-exprimé avec la réplicase ou la nsP4.